Introduction to RNA Vaccines (Q39041939)

8 September 2017

title

Introduction to RNA Vaccines (English)

1 reference

8 September 2017

0 references

Thomas Kramps

1

1 reference

8 September 2017

Knut Elbers

series ordinal

2

1 reference

8 September 2017

language of work or name

English

0 references

publication date

1 January 2017

1 reference

Methods in Molecular Biology

8 September 2017

published in

1 reference

8 September 2017

volume

1499

1 reference

8 September 2017

page(s)

1-11

1 reference

A simplified vaccinologists' vaccinology and the pursuit of a vaccine against AIDS.

8 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-6481-9_1

Vaccinology in the era of high-throughput biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-6481-9_1

Broadly Neutralizing Antibodies Against HIV: New Insights to Inform Vaccine Design.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-6481-9_1

Hepatitis C virus: why do we need a vaccine to prevent a curable persistent infection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-6481-9_1

Vaccines for established cancer: overcoming the challenges posed by immune evasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-6481-9_1

Systems Analysis of Immunity to Influenza Vaccination across Multiple Years and in Diverse Populations Reveals Shared Molecular Signatures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-6481-9_1

Decoding viral infection by ribosome profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-6481-9_1

Neoantigens in cancer immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-6481-9_1

Vaccine manufacturing: challenges and solutions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-6481-9_1

Discovery of T cell antigens by high-throughput screening of synthetic minigene libraries

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-6481-9_1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-6481-9_1

The messenger's great message for vaccination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-6481-9_1

mRNA-based therapeutics--developing a new class of drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-6481-9_1

Vaccines 'on demand': science fiction or a future reality

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-6481-9_1

Messenger RNA-based vaccines: progress, challenges, applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-6481-9_1

Modified mRNA as an alternative to plasmid DNA (pDNA) for transcript replacement and vaccination therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-6481-9_1

Direct gene transfer into mouse muscle in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-6481-9_1

DNA and RNA-based vaccines: principles, progress and prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-6481-9_1

Results of the first phase I/II clinical vaccination trial with direct injection of mRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-6481-9_1

Intradermal vaccinations with RNA coding for TAA generate CD8+ and CD4+ immune responses and induce clinical benefit in vaccinated patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-6481-9_1

Recombinant messenger RNA technology and its application in cancer immunotherapy, transcript replacement therapies, pluripotent stem cell induction, and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-6481-9_1

Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-6481-9_1

RNA as performance-enhancers for dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-6481-9_1

Protective efficacy of in vitro synthesized, specific mRNA vaccines against influenza A virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-6481-9_1

Nonviral delivery of self-amplifying RNA vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-6481-9_1

A cationic nanoemulsion for the delivery of next-generation RNA vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-6481-9_1

Developing mRNA-vaccine technologies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-6481-9_1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-6481-9_1

Lack of interference with immunogenicity of a chimeric alphavirus replicon particle-based influenza vaccine by preexisting antivector immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-6481-9_1

Translation of genomics-guided RNA-based personalised cancer vaccines: towards the bedside

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-6481-9_1

Nucleic acid sensing at the interface between innate and adaptive immunity in vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-6481-9_1

Toll-like receptor-dependent activation of several human blood cell types by protamine-condensed mRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-6481-9_1

Particle size and activation threshold: a new dimension of danger signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-6481-9_1

Messenger RNA-based vaccines with dual activity induce balanced TLR-7 dependent adaptive immune responses and provide antitumor activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-6481-9_1

Nucleic acid recognition by the innate immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-6481-9_1

Innate immune sensing and signaling of cytosolic nucleic acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-6481-9_1

Emerging principles governing signal transduction by pattern-recognition receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-6481-9_1

Nucleic acids and endosomal pattern recognition: how to tell friend from foe?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-6481-9_1

Accessing the therapeutic potential of immunostimulatory nucleic acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-6481-9_1

In situ vaccination: Cancer immunotherapy both personalized and off-the-shelf.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-6481-9_1

21 January 2018

RNA-based viral vectors

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-6481-9_1

Oncolytic viruses and their application to cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-6481-9_1

Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-6481-9_1

Messenger RNA (mRNA) nanoparticle tumour vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-6481-9_1

Intranodal vaccination with naked antigen-encoding RNA elicits potent prophylactic and therapeutic antitumoral immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-6481-9_1

Needle free injection technology: A complete insight

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-6481-9_1

Thermostable Subunit Vaccines for Pulmonary Delivery: How Close Are We?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-6481-9_1

HIV-1 mRNA electroporation of PBMC: a simple and efficient method to monitor T-cell responses against autologous HIV-1 in HIV-1-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-6481-9_1

Efficient mRNA electroporation of peripheral blood mononuclear cells to detect memory T cell responses for immunomonitoring purposes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-6481-9_1

mRNA electroporation as a tool for immunomonitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-6481-9_1

Anti-infective vaccination in the 21st century-new horizons for personal and public health

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-6481-9_1

The complementary roles of Phase 3 trials and post-licensure surveillance in the evaluation of new vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-6481-9_1

Intradermal electroporation of naked replicon RNA elicits strong immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-6481-9_1

Enhanced Delivery and Potency of Self-Amplifying mRNA Vaccines by Electroporation in Situ

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-6481-9_1

Electroporation-enhanced delivery of nucleic acid vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-6481-9_1

The regulatory landscape for actively personalized cancer immunotherapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-6481-9_1

10.1007/978-1-4939-6481-9_1

21 January 2018

Identifiers

DOI

1 reference

release_dyhtw2gqmvdxrkzte5vpf7q424

8 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/dyhtw2gqmvdxrkzte5vpf7q424

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference